A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 15 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Mar 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.